Portfolio (Quarterly)
Guide ↗
Opaleye Management Inc.
· CIK 0001595855| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | GOSS | GOSSAMER BIO INC | Healthcare | 2,720,000.0 | $8.4M | 1.11% | — | — | $3.10 | -93.1% |
| 22 | MBX | MBX BIOSCIENCES INC | Healthcare | 260,000.0 | $8.2M | 1.08% | +7K | +2.8% | $31.54 | -3.6% |
| 23 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 100,000.0 | $8.0M | 1.05% | — | — | $79.65 | +84.9% |
| 24 | XOMA | XOMA CORP DEL | Healthcare | 292,590.0 | $7.8M | 1.03% | +38K | +14.7% | $26.59 | +56.2% |
| 25 | DERM | JOURNEY MEDICAL CORP | Healthcare | 975,000.0 | $7.5M | 0.99% | — | — | $7.71 | -20.0% |
| 26 | KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | 930,000.0 | $6.8M | 0.90% | NEW | — | $7.36 | +8.4% |
| 27 | JBIO | JADE BIOSCIENCES INC | Healthcare | 427,608.0 | $6.6M | 0.87% | NEW | — | $15.43 | +41.8% |
| 28 | URGN | UROGEN PHARMA LTD | Healthcare | 268,423.0 | $6.3M | 0.83% | NEW | — | $23.42 | +20.7% |
| 29 | ALMS | ALUMIS INC | Healthcare | 535,000.0 | $5.2M | 0.69% | -130K | -19.6% | $9.76 | +125.8% |
| 30 | CATX | PERSPECTIVE THERAPEUTICS INC | Healthcare | 1,184,500.0 | $5.0M | 0.66% | NEW | — | $4.21 | -10.5% |
| 31 | VYGR | VOYAGER THERAPEUTICS INC | Healthcare | 1,196,904.0 | $4.7M | 0.62% | NEW | — | $3.93 | -11.5% |
| 32 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 935,000.0 | $4.5M | 0.60% | NEW | — | $4.83 | +45.5% |
| 33 | TECX | TECTONIC THERAPEUTICS INC | Healthcare | 214,747.0 | $4.5M | 0.59% | NEW | — | $20.86 | +30.8% |
| 34 | PLX | PROTALIX BIOTHERAPEUTICS INC | Healthcare | 2,478,176.0 | $4.5M | 0.59% | -102K | -4.0% | $1.80 | +11.7% |
| 35 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 345,100.0 | $4.3M | 0.57% | -45K | -11.5% | $12.52 | +5.8% |
| 36 | — | FORTRESS BIOTECH INC | — | 1,090,000.0 | $4.0M | 0.53% | NEW | — | $3.66 | — |
| 37 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 955,000.0 | $3.4M | 0.44% | NEW | — | $3.51 | -16.8% |
| 38 | MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | 390,844.0 | $3.1M | 0.41% | NEW | — | $7.95 | +14.8% |
| 39 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 70,000.0 | $3.0M | 0.40% | +32K | +85.2% | $42.83 | -33.9% |
| 40 | — | ZYMEWORKS INC | — | 108,929.0 | $2.9M | 0.38% | +9K | +8.9% | $26.33 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%